Rosetta Genomics, Ltd. announced summoning of a shareholders meeting for the purpose of approving the appointment of Yitzhak Peterburg, M.D., Dr.P.H., MSc. to its Board of Directors. Upon approval of this addition by the company's shareholders, the company's Board will consist of seven members.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0001 USD | +9,900.00% | -.--% | -.--% |
2018 | Genoptix, Inc. cancelled the acquisition of Rosetta Genomics Ltd.. | CI |
2018 | Rosetta Genomics Ltd.(NasdaqCM:ROSG) dropped from NASDAQ Composite Index | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 592 | |
+69.48% | 62.86B | |
-0.76% | 41.38B | |
+45.66% | 40.38B | |
-10.72% | 27.64B | |
+14.42% | 26.46B | |
-22.34% | 18.9B | |
+4.81% | 12.67B | |
+23.65% | 12.27B | |
+28.25% | 12.07B |
- Stock Market
- Equities
- ROSGQ Stock
- News Rosetta Genomics Ltd.
- Rosetta Genomics to Appoint Dr. Yitzhak Peterburg to its Board of Directors